Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: Critical role of BDNF and dopamine

Frontiers in Pharmacology

Volumn 5, Issue NOV, 2014, Pages

  Collo, Ginetta ^a   Cavalleri, Laura ^a   Spano, Pier Franco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CANNABINOID; COCAINE; DIAMORPHINE; DOPAMINE; DOPAMINE TRANSPORTER; G PROTEIN COUPLED RECEPTOR; METHAMPHETAMINE; MORPHINE; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; NEUROTROPHIC FACTOR; NICOTINE; OPIATE; PSYCHOSTIMULANT AGENT; TROPOMYOSIN; TYROSINE 3 MONOOXYGENASE;

COCAINE DEPENDENCE; CONNECTOME; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG ABUSE; EPIGENETICS; GENETIC PREDISPOSITION; HUMAN; MESENCEPHALON; MOLECULAR MECHANICS; NERVE CELL PLASTICITY; NEUROIMAGING; NONHUMAN; PROTEIN PHOSPHORYLATION; SHORT SURVEY; VENTRAL TEGMENTUM;

EID: 84910672519     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00259     Document Type: Short Survey

References (76)

1. Argilli, E., Sibley, D. R., Malenka, R. C., England, P. M., Bonci, A. (2008). Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J. Neurosci. 28, 9092-100. doi: 10.1523/JNEUROSCI.1001-08.2008.
2. Baquet, Z. C., Bickford, P. C., Jones, K. R. (2005). Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J. Neurosci. 25, 6251-9.
3. Beom, S. R., Cheong, D., Torres, G., Caron, M. G., Kim, K. M. (2004). Comparative studies of molecular mechanisms of dopamine D2 and D3 receptors for the activation of extracellular signal-regulated kinase. J. Biol Chem. 279, 28304-28314.
4. Bonci, A., Williams, J. T. (1997). Increased probability of GABA release during withdrawal from morphine. J Neurosci. 17, 796-803.
5. Chang, L., Alicata, D., Ernst, T., Volkow, N. (2007). Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102 Suppl. 1, 16-32.
6. Chen, B. T., Hopf, F. W., Bonci, A. (2010). Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse. Ann. N. Y. Acad. Sci. 1187, 129-39. doi: 10.1111/j.1749-6632.2009.05154.x.
7. Collo, G., Zanetti, S., Missale, C., Spano, PF. (2008). Dopamine D3 receptorpreferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation Eur. J. Neurosci. 28,1231-1240. doi: 10.1111/j.1460-9568.2008.06423.x.
8. Collo, G., Bono, F., Cavalleri, L., Plebani, L., Mitola, S., Merlo Pich, E., et al. (2013). Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling. Mol. Pharma. 83, 1176-1189. doi: 10.1124/mol.113.084863.
9. Collo, G., Bono, F., Cavalleri, L., Plebani, L., Merlo, Pich, E., Millan, et al. (2012). Pre-synaptic dopamine D3 receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways. J. Neurochem. 120, 765-778. doi: 10.1111/j.1471-4159.2011.07618.x.
10. Crozatier, C., Guerriero, R. M., Mathieu, F., Giros, B., Nosten-Bertrand, M., Kosofsky, B. E. (2003) Altered cocaine-induced behavioral sensitization in adult mice exposed to cocaine in utero. Brain. Res. Dev. Brain. Res., 147, 97-105.
11. Cussac, D., Newman-Tancredi, A., Pasteau, V., Millan, M. J. (1999). Human dopamine D(3) receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism. Mol. Pharmacol. 56, 1025-30.
12. Del'guidice, T., Lemasson, M., Beaulieu, J. M. (2011). Role of beta-arrestin 2 downstream of dopamine receptors in the basal ganglia. Front. Neuroanat. doi: 10.3389/fnana.2011.00058.
13. Diana, M., Pistis, M., Muntoni, A., Gessa, G. (1995). Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther. 72, 781-785.
14. Diana, M., Melis, M., Muntoni, A. L., Gessa, G. L. (1998). Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc. Natl. Acad. Sci. U S A 95, 10269-71023.
15. Diaz-Ruiz, O., Zapata, A., Shan, L., Zhang, Y., Tomac, A. C., Malik, N., et al. (2009). Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons. PLoS One. 4:e7027. doi: 10.1371/journal.pone.0007027
16. Di Chiara, G. (1995). The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38, 95-137
17. Everitt, B. J., Dickinson, A., Robbins, T. W. (2001). The neuropsychological basis of addictive behaviour. Brain Res. Brain Res. Rev. 36, 129-138.
18. Gilman, J. M., Kuster, J. K., Lee, S., Lee, M. J., Kim, B. W., Makris, N., et al. (2014). Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J. Neurosci. 34, 5529-38. doi: 10.1523/JNEUROSCI.4745-13.2014.
19. Graham, D. L., Edwards, S., Bachtell, R. K., DiLeone, R. J., Rios, M., Self, D. W. (2007). Dynamic BDNF activity in nucleus accumbens with cocaine use increases selfadministration and relapse. Nat. Neurosci. 10, 1029-1037.
20. Grimm, J. W., Lu, L., Hayashi, T., Hope, B. T., Su, T. P., Shaham, Y. (2003). Timedependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci. 23, 742-7.
21. Guillin, O., Griffon, N., Bezard, E., Leriche, L., Diaz, J., Gross, C., et al. (2003). Brain-derived neurotrophic factor controls dopamine D3 receptor expression: Therapeutic implications in Parkinson's disease. Eur. J. Pharmacol. 480, 89-95.
22. Hamad, M. I., Ma-Högemeier, Z. L., Riedel, C., Conrads, C., Veitinger, T., Habijan, T., et al. (2011). Cell class-specific regulation of neocortical dendrite and spine growth by AMPA receptor splice and editing variants. Development. 138, 4301-13.
23. Ikemoto, S., Bonci, A. (2014). Neurocircuitry of drug reward. Neuropharmacol. 76, 329-41. doi: 10.1016/j.neuropharm.2013.04.031.
24. Iwakura, Y., Nawa, H., Sora, I., Chao, M. V. (2008). Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons. J. Biol. Chem. 283, 15799-806. doi: 10.1074/jbc. M801553200.
25. Kalivas, P. W., O'Brien, C. (2008). Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacol. 33, 166-180.
26. Kish, S. J., Kalasinsky, K. S., Derkach, P., Schmunk, G. A., Guttman, M., Ang, L., et al. (2001). Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology. 24, 561-7.
27. Koo, J. W., Mazei-Robison, M. S., Chaudhury, D., Juarez, B., LaPlant, Q., Ferguson, D., et al. (2012). BDNF is a negative modulator of morphine action. Science. 338, 124-8. doi: 10.1126/science.1222265.
28. Koob, G. F. (1992). Dopamine, addiction and reward. Semin. Neurosci. 4,139-148.
29. Koob, G. F., Le Moal, M. (2005). Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 8, 1442-1444.
30. Koob, G. F. (2013). Addiction is a Reward Deficit and Stress Surfeit Disorder. Front. Psychiatry. 4, 72. doi: 10.3389/fpsyt.2013.00072. eCollection 2013
31. Köhler, C., Goldstein, M. (1984). Golgi-like immunoperoxidase staining of dopamine neurons in the reticular formation of the rat brain stem using antibody to tyrosinehydroxylase. J. Comp. Neurol. 223, 302-11.
32. Kumar, V., Zhang, M. X., Swank, M. W., Kunz, J., Wu, G. Y. (2005). Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J. Neurosci. 25, 11288-99.
33. Juraska, J. M., Wilson, C. J., Groves, P. M. (1977). The substantia nigra of the rat: a Golgi study. J. Comp. Neurol. 172, 585-600.
34. Le Foll, B., Diaz, J., SokoloffP. (2005). A single cocaine exposure increases BDNF and D3 receptor expression: Implications for drug-conditioning. NeuroReport 16, 175-178.
35. Le Foll, B., Diaz, J., Sokoloff, P. (2005). Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Life Sci. 76, 1281-96.
36. Leroy, C., Karila, L., Martinot, J. L., Lukasiewicz, M., Duchesnay, E., Comtat, C., et al. (2012). Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addict. Biol. 17, 981-90. doi: 10.1111/j.1369-1600.2011.00356.x.
37. Lichtman, A. H., Sheikh, S. M., Loh, H. H., Martin, B. R. (2001). Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. J Pharmacol. Exp. Ther. 298, 1007-14.
38. Little, K. Y., Ramssen, E., Welchko, R., Volberg, V., Roland, C. J., Cassin, B. (2009). Decreased brain dopamine cell numbers in human cocaine users. Psychiatry Res. 168, 173-80. doi: 10.1016/j.psychres.2008.10.034.
39. Lu, L., Dempsey, J., Liu, S. Y., Bossert, J. M., Shaham, Y. (2004). A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci. 24, 1604-11. doi: 10.1016/j.biopsych. 2009.02.009.
40. Lu, L., Wang, X., Wu, P., Xu, C., Zhao, M., Morales, M., et al. (2009). Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry. 66, 137-45.
41. Lloyd, S. A., Oltean, C., Pass, H., Phillips, B., Staton, K., Robertson, C. L., et al. (2013). Prenatal exposure to psychostimulants increases impulsivity, compulsivity, and motivation for reward in adult mice. Physiol. Behav. 119, 43-51. doi: 10.1016/j.physbeh.2013.05.038.
42. Maina, F. K., Mathews, T. A. (2010). A functional fast scan cyclic voltammetry assay to characterize dopamine D2 and D3 autoreceptors in the mouse striatum. ACS Chem Neurosci. 1, 450-462.
43. Martinez, D., Greene, K., Broft, A., Kumar, D., Liu, F., Narendran, R., et al. (2009). Lower level of endogenous dopamine in patients with cocaine dependence: Findings from PET imaging of D2/D3 receptors following acute dopamine depletion. Am. J. of Psychiatry. 166, 1170-1177. doi: 10.1176/appi.ajp.2009.08121801.
44. Mazei-Robison, M. S., Koo, J. W., Friedman, A. K., Lansink, C. S., Robison, A. J., Vinish, et al. (2011). Role for mTOR signaling and neuronal activity in morphineinduced adaptations in ventral tegmental area dopamine neurons. Neuron. 72, 977-90. doi: 10.1016/j.neuron.2011.10.012.
45. Melis, M., Spiga, S., Diana, M. (2005). The dopamine hypothesis of drug addiction: hypodopaminergic state. Int. Rev. Neurobiol. 63, 101-154.
46. Mueller, D., Chapman, C. A., Stewart, J. (2006). Amphetamine induces dendritic growth in ventral tegmental area dopaminergic neurons in vivo via basic fibroblast growth factor. Neurosci 137, 727-35.
47. Nestler, E. J. (1992). Molecular mechanism of drug addiction. J. Neurosci. 12, 2439-2450.
48. Nestler, E. J. (2013). Cellular basis of memory for addiction. Dialogues Clin. Neurosci. 15, 431-43.
49. Ohira, K., Hayashi, M. (2009). A new aspect of the TrkB signaling pathway in neural plasticity. Curr. Neuropharmacol. 7, 276-85. doi: 10.2174/157015909790031210.
50. Picciotto, M. R., Zoli M., Rimondini, R., Léna C., Marubio, L. M., Pich, E. M., et al. (1998). Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173-177.
51. Pitchers, K. K., Coppens, C. M., Beloate, L. N., Fuller, J., Van S., Frohmader, K. S., et al. (2014). Endogenous opioid-induced neuroplasticity of dopaminergic neurons in the ventral tegmental area influences natural and opiate reward. J. Neurosci. 34, 8825-36. doi: 10.1523/JNEUROSCI.0133-14.2014.
52. Pu, L., Liu, Q. S., Poo, M. M. (2006). BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat. Neurosci. 9, 605-7.
53. Real, C. C., et al. (2013). BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's disease. Neurosci. 237, 118-129. doi: 10.1016/j.neuroscience.2013.01.060.
54. Robinson, T. E., Kolb, B. (2004). Structural plasticity associated with exposure to drugs of abuse. Neuropharmacol. 47 (Suppl. 1), 33-46.
55. Robinson, T. E., Kolb, B. (1997). Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci. 17, 8491-7.
56. Russo, S. J., Bolanos, C. A., Theobald, D. E., DeCarolis, N. A., Renthal, W., Kumar, A., et al. (2007). IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat. Neurosci. 10, 93-99. doi: 10.1016/j.neuropharm.2008.06.059.
57. Russo, S. J., Mazei-Robison, M. S., Ables, J. L., Nestler, E. J. (2009). Neurotrophic factors and structural plasticity in addiction. Neuropharmacol. 56, 73-82.
58. Russo, S. J., Dietz, D. M., Dumitriu, D., Morrison, J. H., Malenka, R. C., Nestler, E. J. (2010). The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends in Neurosci. 33, 267-76. doi: 10.1016/j.tins.2010.02.002.
59. Sarti, F., Borgland, S. L., Kharazia, V. N., Bonci, A. (2007). Acute cocaine exposure alters spine density and long-term potentiation in the ventral tegmental area. Eur. J. Neurosci. 26, 749-56.
60. Schilström, B., Yaka, R., Argilli, E., Suvarna, N., Schumann, J., Chen, B.T., et al. (2006). Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors. J Neurosci. 26, 8549-58.
61. Schmitz, Y., Luccarelli, J., Kim, M., Wang, M., Sulzer, D. (2009). Glutamate controls growth rate and branching of dopaminergic axons. J. Neurosci. 29, 11973-81. doi: 10.1523/JNEUROSCI.2927-09.2009.
62. Shimoda, K., Sauve, Y., Marini, A., Schwartz, J. P., Commissiong, J. W. (1992). A high percentage yield of tyrosine hydroxylase-positive cells from rat E14 mesencephalic cell culture. Brain Res. 586, 319-31.
63. Sklair-Tavron, L., Shi, W. X., Lane, S. B., Harris, H. W., Bunney, B. S., Nestler, E. J. (1996). Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. U S A. 93, 11202-7.
64. Spiga, S., Serra, G. P., Puddu, M. C., Foddai, M., Diana, M. (2003). Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur. J. Neurosci. 17, 605-612.
65. Spiga, S., Lintas, A., Migliore, M., Diana, M. (2010). Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence. Addict. Biol. 15, 266-76. doi: 10.1111/j.1369-1600.2010.00218.x.
66. Spiga, S., Acquas, E., Puddu, M. C., Mulas, G., Lintas, A., Diana, M. (2011). Simultaneous Golgi-Cox and immunofluorescence using confocal microscopy. Brain Struct. Funct. 216, 171-82. doi: 10.1007/s00429-011-0312-2.
67. Spangler, R., Goddard, N. L., Avena, N. M., Hoebel, B. G., Leibowitz, S. F. (2003). Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine. Brain Res. Mol. Brain Res. 111, 74-83.
68. Thompson, J. L., Urban, N., Slifstein, M., Xu, X., Kegeles, L. S., Girgis, R. R., et al. (2013). Striatal dopamine release in schizophrenia comorbid with substance dependence. Mol. Psychiatry. 18, 909-15. doi: 10.1038/mp.2012.109.
69. Van-Ham, I. I., Banihashemi, B., Wilson, A. M., Jacobsen, K. X., Czeak, M., Albert, P. R. (2007). Differential signaling of dopamine-D2S and -D2L receptors to inhibit ERK1/2 phosphorylation. J. Neurochem. 102, 1796-804.
70. Vargas-Perez, H., Bahi, A., Bufalino, M. R., Ting-A-Kee, R., Maal-Bared, G., Lam, J., et al. (2014). BDNF signaling in the VTA links the drug-dependent state to drug withdrawal aversions. J. Neurosci. 34, 7899-909. doi: 10.1523/JNEUROSCI.3776-13.2014.
71. Vargas-Perez, H., Ting-A Kee, R., Walton, C. H., Hansen, D. M., Razavi, R., Clarke, L., et al. (2009). Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats. Science. 324, 1732-4. doi: 10.1126/science.1168501.
72. Volkow, N. D., Wang, G. J., Telang, F., Fowle, J. S., Alexoff, D., Logan, J., et al. (2014). Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc. Natl. Acad. Sci. U S A. 111, E3149-56. doi: 10.1073/pnas.1411228111.
73. Walhovd, K. B., Moe, V., Slinning, K., Due-Tønnessen, P., Bjørnerud, A., Dale, A. et al. (2007). Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage. 36, 1331-44.
74. Weiss, F., Markou, A., Lorang, M. T., Koob, G. F. (1992). Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 593, 314-8.
75. Zhang, L., Dong, Y., Doyon, W. M., Dani, J. A. (2012). Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens. Biol. Psychiatry. 71, 184-91. doi: 10.1016/j.biopsych.2011.07.024.
76. Zhang, H., Sulzer, D. (2012). Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors. Basal Ganglia. 2, 5-13.